Ducommun Reaches New 52-Week High at $31.37 (DCO)
Ducommun (NYSE:DCO) shares reached a new 52-week high during trading on Monday , Analyst Ratings Network.com reports. The stock traded as high as $31.37 and last traded at $30.90, with a volume of 62,909 shares traded. The stock had previously closed at $29.97.
A number of research firms have recently commented on DCO. Analysts at Zacks upgraded shares of Ducommun from a “neutral” rating to an “outperform” rating in a research note on Wednesday, July 30th. They now have a $29.80 price target on the stock. Separately, analysts at DA Davidson upgraded shares of Ducommun from a “neutral” rating to a “buy” rating in a research note on Tuesday, July 29th. They now have a $28.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Topeka Capital Markets initiated coverage on shares of Ducommun in a research note on Tuesday, June 24th. They set a “hold” rating and a $27.00 price target on the stock. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. Ducommun presently has an average rating of “Buy” and a consensus price target of $31.26.
The stock has a 50-day moving average of $26.06 and a 200-day moving average of $25.68. The company has a market cap of $335.5 million and a price-to-earnings ratio of 29.50.
Ducommun (NYSE:DCO) last posted its quarterly earnings results on Monday, July 28th. The company reported $0.59 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.44 by $0.15. The company had revenue of $186.50 million for the quarter, compared to the consensus estimate of $189.63 million. During the same quarter in the prior year, the company posted $0.51 earnings per share. The company’s quarterly revenue was down 2.6% on a year-over-year basis. Analysts expect that Ducommun will post $1.92 EPS for the current fiscal year.
Ducommun Incorporated (NYSE:DCO) provides engineering and manufacturing services primarily in the aerospace, defense, industrial, energy, and medical industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.